Tianjin Ringpu reports FY24 results, plans capital return

Tianjin Ringpu Bio-Technology (SZSE:300119) announced its FY24 results and outlined plans for shareholder returns, including a cash dividend and share repurchase program. The company reported FY24 revenue of CNY3.07 billion, a 13.32% increase year-over-year. Net profit attributable to shareholders reached CNY301 million, a 33.70% decrease compared to the previous year. The firm has proposed a cash dividend of CNY3.00 per 10 shares, totaling CNY136.73 million, subject to shareholder approval. Additionally, the company will allocate CNY115.06 million to repurchase shares for equity incentives or employee stock ownership. Alongside the financial results, the company disclosed related actions from recent months, including the buyback progress and proposed adjustments to its equity incentive plan. The firm plans to call a shareholder meeting to approve these actions.